These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26444103)

  • 21. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.
    Naganuma M; Kunisaki R; Yoshimura N; Nagahori M; Yamamoto H; Kimura H; Sako M; Kawaguchi T; Takazoe M; Yamamoto S; Matsui T; Hibi T; Watanabe M
    J Crohns Colitis; 2011 Aug; 5(4):317-23. PubMed ID: 21683301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuing immunomodulators and biologic medications in pregnant IBD patients - sometimes con.
    Korelitz BI
    Inflamm Bowel Dis; 2007 Nov; 13(11):1441-2; discussion 1443-5. PubMed ID: 17828779
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-TNF therapy in inflammatory bowel diseases during pregnancy and breast-feeding].
    Persić M
    Acta Med Croatica; 2013 Apr; 67(2):157-64. PubMed ID: 24471298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis.
    Gubatan J; Barber GE; Nielsen OH; Juhl CB; Maxwell C; Eisenberg ML; Streett SE
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2222-2238. PubMed ID: 35870769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.
    van Hoeve K; Vermeire S
    Paediatr Drugs; 2020 Oct; 22(5):449-461. PubMed ID: 32797366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis.
    Qiu Y; Mao R; Chen BL; Zhang SH; Guo J; He Y; Zeng ZR; Ben-Horin S; Chen MH
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1359-1372.e6. PubMed ID: 28232073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammatory bowel disease and pregnancy].
    Lukás K; Parízek A; Kotlas J; Novotný A
    Cas Lek Cesk; 2010; 149(4):163-4, 166-72. PubMed ID: 20518249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.
    Habal FM; Huang VW
    Aliment Pharmacol Ther; 2012 Mar; 35(5):501-15. PubMed ID: 22221203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of inflammatory bowel disease in pregnancy.
    Vermeire S; Carbonnel F; Coulie PG; Geenen V; Hazes JM; Masson PL; De Keyser F; Louis E
    J Crohns Colitis; 2012 Sep; 6(8):811-23. PubMed ID: 22595185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical Therapy for Inflammatory Bowel Disease.
    Grevenitis P; Thomas A; Lodhia N
    Surg Clin North Am; 2015 Dec; 95(6):1159-82, vi. PubMed ID: 26596920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review.
    Gisbert JP; Chaparro M
    Drugs; 2020 Jul; 80(11):1085-1100. PubMed ID: 32562207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.
    Puchner A; Gröchenig HP; Sautner J; Helmy-Bader Y; Juch H; Reinisch S; Högenauer C; Koch R; Hermann J; Studnicka-Benke A; Weger W; Puchner R; Dejaco C
    Wien Klin Wochenschr; 2019 Jan; 131(1-2):29-44. PubMed ID: 30643992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.
    Nielsen OH; Loftus EV; Jess T
    BMC Med; 2013 Jul; 11():174. PubMed ID: 23902720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updates in the management of inflammatory bowel disease during pregnancy.
    Bell SJ; Flanagan EK
    Med J Aust; 2019 Apr; 210(6):276-280. PubMed ID: 30905081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.
    Lee S; Seow CH; Adhikari K; Metcalfe A
    Aliment Pharmacol Ther; 2020 Mar; 51(5):544-552. PubMed ID: 31797416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are biological drugs safe in pregnancy?
    Calligaro A; Hoxha A; Ruffatti A; Punzi L
    Reumatismo; 2015 Mar; 66(4):304-17. PubMed ID: 25829190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug transfer to the fetus and to the breastfeeding infant: what do we know?
    Bernick SJ; Kane S
    Curr Drug Deliv; 2012 Jul; 9(4):350-5. PubMed ID: 22762278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
    Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heading back to the trough (levels of biologics in IBD).
    Hanauer SB
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):548-51. PubMed ID: 25311382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.